Literature DB >> 4943186

Interactions between sympathomimetic amines and a new monoamine oxidase inhibitor.

M H Lader, G Sakalis, M Tansella.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4943186     DOI: 10.1007/bf00402391

Source DB:  PubMed          Journal:  Psychopharmacologia


× No keyword cloud information.
  20 in total

Review 1.  Monoamine oxidase inhibitors revisited.

Authors:  D G Wells; A R Bjorksten
Journal:  Can J Anaesth       Date:  1989-01       Impact factor: 5.063

Review 2.  Inhibitors of MAO-B and COMT: their effects on brain dopamine levels and uses in Parkinson's disease.

Authors:  John P M Finberg
Journal:  J Neural Transm (Vienna)       Date:  2018-11-01       Impact factor: 3.575

3.  Enhanced pressor sensitivity to oral tyramine challenge following high dose selegiline treatment.

Authors:  A Prasad; V Glover; B L Goodwin; M Sandler; M Signy; S E Smith
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 4.  The discovery and development of rasagiline as a new anti-Parkinson medication.

Authors:  John P M Finberg
Journal:  J Neural Transm (Vienna)       Date:  2020-01-23       Impact factor: 3.575

5.  Relationship between tyramine potentiation and selective inhibition of monoamine oxidase types A and B in the rat vas deferens.

Authors:  J P Finberg; M Tenne
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

6.  Absence of "cheese effect" during deprenyl therapy: some recent studies.

Authors:  M Sandler; V Glover; A Ashford; G M Stern
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

7.  Recent observations on the clinical pharmacology of (-)deprenyl.

Authors:  G M Stern; A J Lees; M Sandler
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

8.  Tyramine pressor sensitivity in healthy subjects during combined treatment with moclobemide and selegiline.

Authors:  A Korn; B Wagner; E Moritz; J Dingemanse
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

9.  Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to oral tyramine in man.

Authors:  A Martini; L Bonollo; F B Nicolis; R Sega; A Palermo
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

10.  Tyramine-induced noradrenaline release from rat brain slices: prevention by (-)-deprenyl.

Authors:  V Glover; C J Pycock; M Sandler
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.